Patents by Inventor Ely J. Rubin

Ely J. Rubin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tumor treatment process and composition
    Patent number: 4895874
    Abstract: Saturated aliphatic straight chain dicarboxylic acids having a total number of carbon atoms which are divisible by four, are selectively toxic to certain tumor cells while non-toxic to normal cells of the same origin. Octacosanedioic acid is particularly preferred as it is a component of normal blood serum. Compositions containing these compounds may be used in the treatment of certain malignancies.
    Type: Grant
    Filed: March 1, 1984
    Date of Patent: January 23, 1990
    Assignees: David Rubin, Ely J. Rubin, Adolf W. Schwimmer, Irwin S. Schwartz, Century Laboratories, Inc.
    Inventors: David Rubin, Ely J. Rubin
  • Mandelonitrile triacetyl glucuronate and process for preparing same
    Patent number: 4490523
    Abstract: Mandelonitrile-.beta.-D-glucuronic acid can be produced by tritylating mandelonitrile-.beta.-D-glucoside, acetylating the obtained product, and then simultaneously detritylating and oxidizing in order to obtain mandelonitrile-.beta.-D-triacetyl glucuronic acid. This compound may then be deacetylated to obtain mandelonitrile-.beta.-D-glucuronic acid or the salt thereof.
    Type: Grant
    Filed: November 10, 1981
    Date of Patent: December 25, 1984
    Assignees: Ely J. Rubin, David Rubin, Century Science Corp.
    Inventors: Ely J. Rubin, Israel Shahak